Dr. Ing. h.c. F. Porsche AG (DRPRF)
ValueMarkers Composite Index
81% below intrinsic value ($279)
Dr. Ing. h.c. F. Porsche AG (DRPRF) — VMCI valuation read
DRPRF screens at VMCI 56/100, a 6-point gap above the Consumer Cyclical sector median (50). For a mid-cap Dr. Ing. h.c. F. Porsche AG share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.
DRPRF has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.
**Investor frame.** Value: DRPRF trades at 24.0x earnings, 33% above the Consumer Cyclical median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Consumer Cyclical group. Quality: ROIC of 8.0% trails the Consumer Cyclical median (10.0%) by 2.0pp, the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 2.1x is the rate-sensitivity line to watch, which sets the rate-cycle exposure for Dr. Ing. h.c. F. Porsche AG.
DRPRF rose 0.3% over the trailing 7 days, with a -11.0% read on a 30-day basis.
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services businesses. The company engages in the development, manufacturing, and sale of vehicles, as well as provision of related services. It also offers customer and dealer financing, leasing, and mobility and other finance-related services; and accessories and fashion products. The company was formerly known as Porsche Fünfte Vermögensverwaltung AG and changed its name to Dr. Ing. h.c. F. Porsche AG in November 2009. The company was founded in 2009 and is based in headquartered in Stuttgart, Germany. Dr. Ing. h.c. F. Porsche AG operates as a subsidiary of Porsche Holding Stuttgart GmbH.
Related Stocks in Consumer Cyclical
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.